Use of morphine in the symptomatic management of dyspnea in patients with COVID-19

Authors

DOI:

https://doi.org/10.35434/rcmhnaaa.2021.14Sup1.1182

Abstract

Letter to the Editor (without abstract)

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biographies

Johan Azañero-Haro, Medico Internista

  1. Departamento de Medicina Interna, Hospital Nacional Hipólito Unánue, Lima, Perú.
  2. Escuela de postgrado, Universidad Científica del Sur, Lima, Perú.

Alonso Soto, Médico Internista, PhD en Ciencias Biomédicas

  1. Departamento de Medicina Interna, Hospital Nacional Hipólito Unánue, Lima, Perú.
  2. Instituto de Investigaciones en Ciencias Biomédicas (INICIB), Facultad de Medicina. Universidad Ricardo Palma. Lima, Perú.

Additional Files

Published

2021-11-14

How to Cite

1.
Azañero-Haro J, Soto A. Use of morphine in the symptomatic management of dyspnea in patients with COVID-19. Rev. Cuerpo Med. HNAAA [Internet]. 2021 Nov. 14 [cited 2024 May 18];14(Supl. 1):88-9. Available from: https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1182

Issue

Vol. 14 No. Supl. 1 (2021): SARS-CoV-2, COVID-19 y Pandemia

Section

Letter to the editor
Crossref
Scopus
Google Scholar
Europe PMC